Articles From: MergeWorthRx Corp. Announces Record and Meeting Dates for Special Meeting Relating to Previously Announced Proposed Business Combination With AeroCare Holdings, Inc. to Merrimack Pharmaceuticals Receives FDA Fast Track Designation for MM-398 in Post-Gemcitabine Metastatic Pancreatic Cancer


Meridian Bioscience, Inc. (NASDAQ: VIVO): GENERAL HIGHLIGHTS Meridian Bioscience, Inc. (NASDAQ: VIVO) today: reported fourth quarter and full-year fiscal 2014 net revenues of $46.7 million and $188.8 million, respectively, a decrease of 5% and an increase of less than 1%, respectively, from the same periods of the prior fiscal year; reported fourth quarter and full-year fiscal 2014 operating income of $12.0 million and $52.4 million, respectively, decreases of 10% and 9%, respectively, from the same periods of the prior fiscal year; reported fourth quarter fiscal 2014 net earnings of $8.2 million, or $0.20 per diluted share, decreases of 11% and 9%, respectively, compared to the fiscal 2013 fourth quarter; reported full-year fiscal 2014 net
Sign-up for Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2015 Guidance investment picks
KANSAS CITY, Mo., Dec.
Sign-up for Meridian Health Joins Cerner to Aggregate Population Health Data Across Multiple EHRs investment picks
Meridian Life Science, Inc., (MLS) of Memphis, Tennessee, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce they have been selected by the Centers for Disease Control and Prevention (CDC) to develop a process for manufacture of a rotavirus vaccine.
Sign-up for Meridian Life Science Awarded SBIR II by Centers for Disease Control and Prevention to Develop Rotavirus Vaccine investment picks
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced its wholly owned subsidiary, Meridian Life Science, Inc. (MLS) has opened a new office in Beijing, China.
Sign-up for Meridian Opens a New Office in Beijing, China investment picks
SOUTH JORDAN, Utah, Oct.
Sign-up for Merit Medical and Bard Access Systems, Inc. Settle Dispute investment picks
SOUTH JORDAN, Utah, Dec.
Sign-up for Merit Medical Announces Multiple Regulatory Approvals investment picks
Revenues Up 12% for Third Quarter Gross Margin Up 140 Basis Points Sequentially from Second Quarter Income from Operations Improves to 9.4% for Third Quarter Third Quarter SG&A Expenses Down 180 Basis Points Sequentially Non-GAAP EPS $0.25 for Third Quarter Relocation to Pearland, Texas Completed PreludeEASE ™ Hydrophilic Sheath Receives 510(k) Clearance SOUTH JORDAN, Utah, Oct.
Sign-up for Merit Medical Announces Results for the Quarter Ended September 30, 2014 investment picks
Fourth Quarter and Year End Results Scheduled for Release on February 24, 2015 SOUTH JORDAN, Utah, Jan.
Sign-up for Merit Medical Systems Announces Dates for Earnings Release and Investor Day investment picks
SOUTH JORDAN, Utah, Nov.
Sign-up for Merit Medical to Participate at Piper Jaffray Healthcare Conference investment picks
SOUTH JORDAN, Utah, Nov.
Sign-up for Merit Medical to Present at Stephens and Canaccord Genuity Conferences This Month investment picks
SOUTH JORDAN, Utah, Oct.
Sign-up for Merit Medical Unveils New ThinkRadial(TM) Website and Educational Initiative investment picks
Meritage Homes Corporation (NYSE: MTH), a leading U.S. homebuilder, plans to release the Company's fourth quarter and full year 2014 results on Thursday, January 29, 2015 before the market opens.
Sign-up for Meritage Homes Fourth Quarter 2014 Earnings Release and Webcast Conference Call Scheduled for January 29, 2015 investment picks
Meritage Homes Corporation (NYSE: MTH), a leading U.S. homebuilder, today announced third quarter results for the period ended September 30, 2014.
Sign-up for Meritage Homes Reports Results for the Third Quarter of 2014 investment picks
Meritage Homes Corporation (NYSE: MTH), a leading U.S. homebuilder, announced today that Meritage management will be speaking to investors at the Southwest IDEAS Investor Conference on November 20, 2014 at the Marriott – Quorum Hotel in Addison, Texas.
Sign-up for Meritage Homes to Present at the Southwest IDEAS Investor Conference on November 20th in Dallas investment picks
Company Announces Full Fiscal Year Adjusted EBITDA Margin Improvement of 110 Basis Points Year-Over-Year TROY, Mich.
Sign-up for Meritor Reports Fourth Quarter and Fiscal Year 2014 Results investment picks
TROY, Mich.
Sign-up for Meritor® to Host Analyst Day in New York on Feb. 5 investment picks
2014/10/27
Feelings of guilt over not investing enough this year outpace common year-end regrets such as poor eating and drinking choices, not sharing enough time with loved ones or spending too much money on oneself.
Sign-up for Merrill Edge® Survey Finds Americans Feel Guilty About Not Investing Enough in 2014, Set Their Sights Higher for 2015 investment picks
Bank of America’s Global Wealth and Investment Management (GWIM) division today announced that it has signed the United Nations-supported Principles for Responsible Investment (PRI) on behalf of its discretionary asset management businesses.
Sign-up for Merrill Lynch and U.S. Trust Sign the United Nations Principles for Responsible Investment investment picks
CAMBRIDGE, Mass., Dec.
Sign-up for Merrimack Pharmaceuticals Announces the Addition of Russell T. Ray to Its Board of Directors investment picks
CAMBRIDGE, Mass., Nov.
Sign-up for Merrimack Pharmaceuticals Announces Timing of Third Quarter 2014 Investor Conference Call investment picks
Clinical data from Phase 1 studies of MM-398 and MM-151 presented BARCELONA, Spain, Nov.
Sign-up for Merrimack Pharmaceuticals Presents on Multiple Programs at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: MergeWorthRx Corp. Announces Record and Meeting Dates for Special Meeting Relating to Previously Announced Proposed Business Combination With AeroCare Holdings, Inc. to Merrimack Pharmaceuticals Receives FDA Fast Track Designation for MM-398 in Post-Gemcitabine Metastatic Pancreatic Cancer
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent